Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2015: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
Outline of Final Research Achievements |
To identify rare variations that have strong impact on the risk of developing schizophrenia, we performed a three-stage study. In the first stage, we identified two rare missense PDCD11 variations (D961N and V1240L) using whole-exome sequencing (WES) data from three families, each with two affected siblings. In the second stage, we identified three rare non-synonymous variations (V1240L, F1835del, and R1837H) via targeted resequencing of the PDCD11 coding region in 96 patients. In the third stage, a case-control study demonstrated no significant associations between schizophrenia and four rare PDCD11 variations in a total of 1,357 patients and 1,394 controls. Our data do not support the role of rare PDCD11 variations in conferring substantial risk for schizophrenia in the Japanese population.
|